Divis Laboratories may test Rs 1750-1780: Prakash Diwan

Prakash Diwan of Altamount Capital Management told CNBC-TV18, "Given the kind of momentum that we have seen in Divis Laboratories post their numbers, the stock is just at the beginning of a very promising trajectory. So for the next six to nine months, if that's what correlates with the medium-term, one should be comfortably looking at about Rs 1,750-1,780 kind of a band.”

“If somebody is patient enough to hold the stock for about a year plus-two years then it should be a next big pharmaceutical name with the Rs 2,200 target after 12 months is what we have got.”